alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 101 (Thursday, May 28, 2009)]
[Notices]
[Page 25566]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12391]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Breast and Cervical Cancer Early Detection and Control Advisory 
Committee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Name: Breast and Cervical Cancer Early Detection and Control 
Advisory Committee (BCCEDCAC).
    Times and Dates:

8:30 a.m.-5 p.m., June 16, 2009;
8:30 a.m.-3 p.m., June 17, 2009.

    Place: Centers for Disease Control and Prevention, Tom Harkin 
Global Communications Center, 1600 Clifton Road Building 19, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Secretary, 
Department of Health and Human Services, and the Director, CDC, 
regarding the early detection and control of breast and cervical 
cancer. The committee makes recommendations regarding national 
program goals and objectives; implementation strategies; and program 
priorities including surveillance, epidemiologic investigations, 
education and training, information dissemination, professional 
interactions and collaborations, and policy.
    Matters To Be Discussed: The agenda will include discussion and 
review of the National Cancer Prevention and Control Program 
highlights; Economic crisis in states and impact on the National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP) and 
cancer treatment; HPV DNA testing; Integration of Colorectal Cancer 
screening; Performance based budgeting; Using data to drive program 
planning; Mammography Use 2000-2006 study results; Non-screening 
components of NBCCEDP Public Education and Outreach, Coalitions and 
Partnerships, Quality Assurance and Quality Improvement.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Chastity Walker, Executive 
Secretary, BCCEDCAC, Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 4770 Buford Highway, Mailstop K-57, Chamblee, Georgia 30316, 
Telephone: 770-488-3013.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 21, 2009.
Andre Tyler,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E9-12391 Filed 5-27-09; 8:45 am]
BILLING CODE 4163-18-P
Exhibit 32(a)    CERTIFICATION OF  CHIEF EXECUTIVE OFFICER  PURSUANT TO 18 U.S.C. § 1350

I, J.M. Haggar, III, Chief Executive Officer of Haggar Corp. (the "Company"), hereby certify that the accompanying report on Form 10-K for the
fiscal year ended September 30, 2003, and filed with the Securities and Exchange Commission on the date hereof (the "Report"), fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934, as amended. I further certify that the information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

/s/J. M. HAGGAR, IIIJ. M. Haggar, IIIDate: December 12, 2003


---

QuickLinks
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 904 Engrossed in Senate (ES)]

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
109th CONGRESS
  1st Session
                                 S. 904

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
 at 1560 Union Valley Road in West Milford, New Jersey, as the ``Brian 
                  P. Parrello Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BRIAN P. PARRELLO POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 1560 Union Valley Road in West Milford, New Jersey, shall be 
known and designated as the ``Brian P. Parrello Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Brian P. 
Parrello Post Office Building''.

            Passed the Senate June 29, 2005.

            Attest:

                                                             Secretary.
109th CONGRESS

  1st Session

                                 S. 904

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
 at 1560 Union Valley Road in West Milford, New Jersey, as the ``Brian 
                  P. Parrello Post Office Building''.
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel, ARRA REVISION I.                    

*Date:*                         June 5, 2009.                    

*Time:*                         2 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Bita Nakhai, PhD, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20814. 301-402-7701.                         *nakhaib@nia.nih.gov*.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS)

Dated: May 15, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-12200 Filed 5-22-09; 8:45 am]

BILLING CODE 4140-01-P
China Biologic Products, Inc. - Exhibit 10.23 - Prepared By TNT Filings
Inc.





       




Exhibit 10.23

Plasma Supply Agreement (English Translation) 

Party A: Shandong Missile Biological Product Pty Ltd. 

Party B: Shen County Plasma Collection Station 

For better arrangement of plasma supply and the mutual benefit of both
Parties, it is hereby agreed that: 

1.
    The basic purchase price for
plasma supplied by Party B is set at RMB300,000 per ton. 

2.
    If the plasma contains 4 units
of effective antigen unit or above, Party A will pay additional price of
RMB50,000 per ton. 

3.
    If the plasma contains less than
4 units of effective antigen unit, Party A will pay additional price of
RMB20,000 per ton. 

4.
    Vaccine and testing reagent will
be provided by Party A. 

5.
    Party B shall provide not less
than 4 tonnes of plasma per month. 

6.
    Party A shall pay on behalf of
Party B for the purchase of refrigerated centrifuge, hi-speed refrigerated
centrifuge and manual column chromatography system. The purchase price shall be
off set with the additional price for the antigen plasma once the total antigen
plasma supply reaches 40 tonnes according to the annual plan. 

7.
    This Agreement has two copies
and each Party shall hold one copy. 

8.
    This Agreement shall commence
from May 1, 2006. 

Signed by: 

Party A: Shandong Missile Biological Products Pty Ltd. 

Party B: Shen County Plasma Collection Station
EXHIBIT 31.1**CERTIFICATION**I, Jean-Loup Romet-Lemonne, certify that:1. I have reviewed this quarterly report on Form 10-Q of IDM Pharma, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and have:     a) designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;     b) evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and     c) disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that has materiallyaffected or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing the equivalent functions):     a) all significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and     b) any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.Dated: August 14, 2006       /s/ Jean-Loup Romet-Lemonne Dr. Jean-Loup Romet-Lemonne    Chief Executive Officer
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 598 Introduced in Senate (IS)]

109th CONGRESS
  1st Session
                                 S. 598

To reauthorize provisions in the Native American Housing Assistance and 
 Self-Determination Act of 1996 relating to Native Hawaiian low-income 
    housing and Federal loan guarantees for Native Hawaiian housing.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 10, 2005

  Mr. Inouye introduced the following bill; which was read twice and 
              referred to the Committee on Indian Affairs

_______________________________________________________________________

                                 A BILL

 
To reauthorize provisions in the Native American Housing Assistance and 
 Self-Determination Act of 1996 relating to Native Hawaiian low-income 
    housing and Federal loan guarantees for Native Hawaiian housing.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REAUTHORIZATION.

    Section 824 of the Native American Housing Assistance and Self-
Determination Act of 1996 (25 U.S.C. 4243) is amended by striking 
``fiscal years'' and all that follows and inserting ``fiscal years 2006 
through 2009''.
                                 <all>
```
[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Page 54595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25305]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993-ASTM International

    Notice is hereby given that, on September 8, 2009, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), ASTM International 
(``ASTM'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing additions 
or changes to its standards development activities. The notifications 
were filed for the purpose of extending the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, ASTM has provided an updated list of 
current, ongoing ASTM standards activities originating between May 2009 
and September 2009 designated as work items. A complete listing of ASTM 
work items, along with a brief description of each, is available at 
http://www.astm.org.
    On September 15, 2004, ASTM filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on November 10, 2004 (69 FR 65226).
    The last notification was filed with the Department on May 18, 
2009. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on June 15, 2009 (74 FR 28728).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-25305 Filed 10-21-09; 8:45 am]
BILLING CODE 4410-11-M
ATTORNEY GRIEVANCE COMMISSION * IN THE

OF MARYLAND

* COURT OF APPEALS

* OF MARYLAND

v.

 * Misc. Docket AG No. 20

OLADIPO AKINWUNMI AKIN-DEKO * September Term, 2020

ORDER

Upon consideration of Petition for Disciplinary or Remedial Action of the Attorney 

Grievance Commission of Maryland, filed pursuant to Maryland Rules 19-737 and 19-721,

Bar Counsel’s Response to this Court’s Show Cause Order entered July 13, 2020, and there 

being no response filed by the Respondent, it is this 24th day of September, 2020

ORDERED, by the Court of Appeals of Maryland, that the Respondent, OlaDipo 

Akinwunmi Akin-Deko, be, and hereby is, indefinitely suspended from the practice of law 

in the State of Maryland for violations of Rules 1.1, 1.3, 8.1(b) and 8.4(d); and it is further

ORDERED, that the Clerk of this Court shall strike the name of OlaDipo 

Akinwunmi Akin-Deko from the register of attorneys in this Court and certify that fact to 

the Trustees of the Client Protection Fund of the Bar of Maryland and all Clerks of all 

judicial tribunals in this State in accordance with Maryland Rule 19-761(b).

 /s/ Mary Ellen Barbera

 Chief Judge
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

AURORA LOAN SERVICING, LLC,

Respondent

v.

CRYSTAL M. STEPHENS,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 29 EAL 2017

Petition for Allowance of Appeal from 

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 12th day of June, 2017, the Petition for Allowance of Appeal is 

DENIED.
**Exhibit
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**











In
      connection with the Quarterly Report
      of Cistera Networks, Inc. on Form 10-QSB for the period ending September 30,
      2007, as filed with the Securities and Exchange Commission on the date hereof
      (the “Report”), I, Derek Downs, President  of the Company, certify,
      pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and
      belief:





(1)           the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)           the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.








/s/    Derek
      P. Downs


Derek
      P.
      Downs


President


(Principal
      Executive Officer)








November
      19, 2007








A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement has been
      provided to the Company and will be retained by the Company and furnished to
      the
      Securities and Exchange Commission or its staff upon request.
## I N T H E C O U R T O F C R I M I N A L A P P E A L S O F T E X A S NOS. WR-74,963-02 and 03

EX P ARTE JOSE P ABLO GUARD IOLA, App licant

ON AP P LICATIONS FOR A WRIT OF HABEAS CORPUS CAUSE NOS. 2008CR1071-W1 and 2008CR1072-W1 IN THE 175th DIS TRICT COURT F ROM BEXAR COUNTY

Per curiam . O P I N I O N Pursuant to the provisi o n s o f Ar t icle 11.07 of the Texas Code of Criminal Procedur e, the cler k of t he trial court tr ansm itted to this Court these applications for a writ of habeas corpus. Ex parte Y oung , 418 S.W .2d 824, 826 (Tex. Crim. App. 1967). Applicant was convicted of possession of a c ontrolled substance with intent to deliver and possession of marihuana. H e wa s sentence d to ten y ear s’ imprisonment in each c ause. H e did not appea l these convic tions. Applicant contends, inter alia , that materia l and exculpatory evidenc e was withheld from the defe nse in violation of B r a d y v. Ma ryland , 373 US 83 (1963). Specifica lly , the defe nse was not made awa re of misconduct on the part of the arr estingoffice rs that included lying a bout the use of a conf idential informant in orde r to obtain a sea rch w arr ant.2

The trial court deter

mined that due proce ss was violated in these case s and rec ommends that relief be g rante d on a basis oth er than Brady

. The State ag ree s that relief should be g rante d. We disag ree with the trial court’s conclusion of law, but ag ree that Applicant is entitled to relief

. Whil e it is clea r from the rec ord that the Be x ar County District Attorney ’s Offic e was unawa re of the police misconduct that occur

red in this case , the prosec utor has a duty to pa ss a long evidenc e even if it is only known to the police. Kyles v. W hitley , 115 S.Ct . 1555, 514 U.S. 419, 131 L .Ed. 490 (1995). Relief is g rante d. The judgme nts in Cause Nos. 2008CR1070-W 1 and 2008CR1072-W 1 in the 175t h District Court of Bexar County are set aside, and Applicant is rema nded to the custody of t he S heriff of Bexar County to answe r t he charg es as se t out in the indictments. The trial court shall issue any

nece ssary

bench w arr ant within 10 day s after the mandate of this Court issues. Copies of this opinion shall be sent to the Texas Depa rtment o f Crim in a l Ju s ti c e

– Co r rec tional Institut ions Division and Pardons and Paroles Division.

Deliver ed: J anuar

y 29, 2014 Do not publish
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 655 Engrossed Amendment House (EAH)]

109th CONGRESS

  2d Session

                                 S. 655

_______________________________________________________________________

                               AMENDMENT
                In the House of Representatives, U. S.,

                                                         July 11, 2006.

    Resolved, That the bill from the Senate (S. 655) entitled ``An Act to amend 
the Public Health Service Act with respect to the National Foundation for the 
Centers for Disease Control and Prevention'', do pass with the following

                               AMENDMENT:

    On page 2, line 19, after ``period'' insert: at the end of the second 
sentence
            Attest:

                                                                          Clerk.
```